| Dr Dan Bendtsen, MD | |
|
640 Ulukahiki St, Kailua, HI 96734-4454 | |
| (808) 263-5500 | |
| Not Available |
| Full Name | Dr Dan Bendtsen |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 22 Years |
| Location | 640 Ulukahiki St, Kailua, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306048400 | NPI | - | NPPES |
| 363396 | Medicaid | AZ | |
| 1306048400 | Medicaid | NV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Castle | Kailua, HI | Hospital |
| Kuakini Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Critical Care Hawaii Llc | 5395988315 | 4 |
News Archive
Nanyang Technological University is setting up a new institute to advance research in the life sciences, with a focus on ramping up Singapore's efforts in finding cures for human diseases.
Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that it has earned $4 million in milestone payments upon the initiation of two Phase 1 clinical trials of IPI-145.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
As the new school year begins, many parents with overweight and obese children are worried about how their kids will be treated by other students on the playground and in the classroom.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
› Verified 6 days ago
| Entity Name | Critical Care Hawaii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275970915 PECOS PAC ID: 5395988315 Enrollment ID: O20130823000364 |
News Archive
Nanyang Technological University is setting up a new institute to advance research in the life sciences, with a focus on ramping up Singapore's efforts in finding cures for human diseases.
Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that it has earned $4 million in milestone payments upon the initiation of two Phase 1 clinical trials of IPI-145.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
As the new school year begins, many parents with overweight and obese children are worried about how their kids will be treated by other students on the playground and in the classroom.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dan Bendtsen, MD Po Box 22562, Honolulu, HI 96823-2562 Ph: (808) 375-3249 | Dr Dan Bendtsen, MD 640 Ulukahiki St, Kailua, HI 96734-4454 Ph: (808) 263-5500 |
News Archive
Nanyang Technological University is setting up a new institute to advance research in the life sciences, with a focus on ramping up Singapore's efforts in finding cures for human diseases.
Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that it has earned $4 million in milestone payments upon the initiation of two Phase 1 clinical trials of IPI-145.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
As the new school year begins, many parents with overweight and obese children are worried about how their kids will be treated by other students on the playground and in the classroom.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
› Verified 6 days ago
Dr. Sylvia Wang, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 414 Uluniu St, Kailua, HI 96734 Phone: 808-261-8345 Fax: 808-262-5239 | |
Mr. Howard I Keller, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Aulike St, Suite 601, Kailua, HI 96734 Phone: 808-262-6951 Fax: 808-261-7856 | |
Dr. Jamalah Adeeba Munir, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Ulukahiki St, Kailua, HI 96734 Phone: 808-263-5174 | |
Naoky C Tsai, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Ulukahiki St, Ste 103, Kailua, HI 96734 Phone: 808-263-5174 Fax: 808-266-3614 | |
Dr. Joseph A Palma, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 638 Papalani St, Kailua, HI 96734 Phone: 808-262-9887 Fax: 808-262-7013 | |
Ramy A Badawi, MD, MBBS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Ulukahiki St, Kailua, HI 96734 Phone: 808-793-7747 Fax: 808-625-4808 | |
Dr. Helen Ing, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 642 Ulukahiki St, #211, Kailua, HI 96734 Phone: 808-261-0765 Fax: 808-262-5636 |